1. Nam S, Choi YJ, Kim DW, Park EC, Kang JG. 2019; Risk factors for colorectal cancer in Korea: a population-based retrospective cohort study. Ann Coloproctol. 35:347–356. DOI:
10.3393/ac.2019.10.21. PMID:
31937075. PMCID:
PMC6968718.
Article
2. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. 2004; Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 351:1731–1740. DOI:
10.1056/NEJMoa040694. PMID:
15496622.
Article
3. Huh JW, Maeda K, Liu Z, Wang X, Roslani AC, Lee WY. 2020; Current status of "Watch-and-wait" rectal Cancer treatment in Asia-Pacific countries. Ann Coloproctol. 36:70–77. DOI:
10.3393/ac.2020.01.19. PMID:
32054250. PMCID:
PMC7299564.
Article
4. Kim MJ, Kim TH, Kim DY, Kim SY, Baek JY, Chang HJ, et al. 2015; Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? J Surg Oncol. 111:459–464. DOI:
10.1002/jso.23852. PMID:
25559888.
Article
5. Kim MJ, Jeong SY, Park JW, Ryoo SB, Cho SS, Lee KY, et al. 2019; Oncologic outcomes in patients who undergo neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: a 14-year experience in a single institution. Ann Coloproctol. 35:83–93. DOI:
10.3393/ac.2019.04.22.1. PMID:
31113173. PMCID:
PMC6529756.
Article
6. Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. 2019; Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol. 37:33–43. DOI:
10.1200/JCO.18.00032. PMID:
30403572. PMCID:
PMC6366816.
Article
7. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, et al. 2009; Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 10:1053–1062. DOI:
10.1016/S1470-2045(09)70224-4. PMID:
19767239.
Article
8. Tsukamoto S, Fujita S, Ota M, Mizusawa J, Shida D, Kanemitsu Y, et al. 2020; Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg. 107:586–594. DOI:
10.1002/bjs.11513. PMID:
32162301.
Article
9. Ishihara S, Kanemitsu Y, Murono K, Otani K, Yasuda K, Nishikawa T, et al. 2016; Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis. Int J Colorectal Dis. 31:1315–1321. DOI:
10.1007/s00384-016-2607-5. PMID:
27240821.
Article
10. Kanemitsu Y, Komori K, Shida D, Ochiai H, Tsukamoto S, Kinoshita T, et al. 2017; Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: a comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery. 162:303–314. DOI:
10.1016/j.surg.2017.02.005. PMID:
28366499.
Article
11. Lee D, Matsuda T, Yamashita K, Hasegawa H, Yamamoto M, Kanaji S, et al. 2019; Significance of lateral pelvic lymph node size in predicting metastasis and prognosis in rectal cancer. Anticancer Res. 39:993–998. DOI:
10.21873/anticanres.13204. PMID:
30711986.
Article
12. Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, et al. 2012; Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 13:616–621. DOI:
10.1016/S1470-2045(12)70158-4. PMID:
22591948.
Article
13. Lim SB, Yu CS, Kim CW, Yoon YS, Park SH, Kim TW, et al. 2013; Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. Int J Colorectal Dis. 28:1667–1674. DOI:
10.1007/s00384-013-1761-2. PMID:
23943283.
Article
14. Kim MC, Oh JH. 2021; Lateral lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer: a single-center experience and literature review. Ann Coloproctol. 37:382–394. DOI:
10.3393/ac.2021.00913.0130. PMID:
34961302. PMCID:
PMC8717070.
Article
15. Kim MJ, Chan Park S, Kim TH, Kim DY, Kim SY, Baek JY, et al. 2016; Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node? Surgery. 160:366–376. DOI:
10.1016/j.surg.2016.04.006. PMID:
27233638.
Article
17. Ueno H, Yamauchi C, Hase K, Ichikura T, Mochizuki H. 1999; Clinicopathological study of intrapelvic cancer spread to the iliac area in lower rectal adenocarcinoma by serial sectioning. Br J Surg. 86:1532–1537. DOI:
10.1046/j.1365-2168.1999.01271.x. PMID:
10594501.
Article
18. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, et al. 2007; Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg. 245:80–87. DOI:
10.1097/01.sla.0000225359.72553.8c. PMID:
17197969. PMCID:
PMC1867942.
Article
19. Kusters M, Beets GL, van de Velde CJ, Beets-Tan RG, Marijnen CA, Rutten HJ, et al. 2009; A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg. 249:229–235. DOI:
10.1097/SLA.0b013e318190a664. PMID:
19212175.
Article
20. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, et al. 2008; Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 15:729–737. DOI:
10.1245/s10434-007-9696-x. PMID:
18057989.
Article
21. Kim HJ, Choi GS, Park JS, Park SY, Cho SH, Lee SJ, et al. 2017; Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer. Oncotarget. 8:100724–100733. DOI:
10.18632/oncotarget.20121. PMID:
29246016. PMCID:
PMC5725058.
Article
22. Kim TG, Park W, Choi DH, Park HC, Kim SH, Cho YB, et al. 2014; Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients. Int J Colorectal Dis. 29:193–200. DOI:
10.1007/s00384-013-1797-3. PMID:
24322736.
Article
23. Kusters M, Slater A, Muirhead R, Hompes R, Guy RJ, Jones OM, et al. 2017; What to do with lateral nodal disease in low locally advanced rectal cancer? a call for further reflection and research. Dis Colon Rectum. 60:577–585. DOI:
10.1097/DCR.0000000000000834. PMID:
28481851.
Article
24. Atef Y, Koedam TW, van Oostendorp SE, Bonjer HJ, Wijsmuller AR, Tuynman JB. 2019; Lateral pelvic lymph node metastases in rectal cancer: a systematic review. World J Surg. 43:3198–3206. DOI:
10.1007/s00268-019-05135-3. PMID:
31468119.
Article
25. Watanabe T, Tsurita G, Muto T, Sawada T, Sunouchi K, Higuchi Y, et al. 2002; Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery. 132:27–33. DOI:
10.1067/msy.2002.125357. PMID:
12110792.
Article
26. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watamabe T, et al. 2001; Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum. 44:1274–1280. DOI:
10.1007/BF02234784. PMID:
11584199.
Article
27. Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, et al. 2014; Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol. 21:189–196. DOI:
10.1245/s10434-013-3216-y. PMID:
23963871.
Article
28. Kim YI, Jang JK, Park IJ, Park SH, Kim JB, Park JH, et al. 2020; Lateral lymph node and its association with distant recurrence in rectal cancer: a clue of systemic disease. Surg Oncol. 35:174–181. DOI:
10.1016/j.suronc.2020.08.013. PMID:
32889250.
Article
29. Ogawa S, Hida J, Ike H, Kinugasa T, Ota M, Shinto E, et al. 2016; Selection of lymph node-positive cases based on perirectal and lateral pelvic lymph nodes using magnetic resonance imaging: study of the Japanese Society for Cancer of the Colon and Rectum. Ann Surg Oncol. 23:1187–1194. DOI:
10.1245/s10434-015-5021-2. PMID:
26671038.
Article
30. Ogawa S, Hida J, Ike H, Kinugasa T, Ota M, Shinto E, et al. 2016; The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum. Int J Colorectal Dis. 31:1719–1728. DOI:
10.1007/s00384-016-2641-3. PMID:
27576475.
Article
31. Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, et al. 2019; Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg. 154:e192172. DOI:
10.1001/jamasurg.2019.2172. PMID:
31268504. PMCID:
PMC6613303.
Article
32. Akiyoshi T, Matsueda K, Hiratsuka M, Unno T, Nagata J, Nagasaki T, et al. 2015; Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer. Ann Surg Oncol. 22 Suppl 3:S614–S620. DOI:
10.1245/s10434-015-4565-5. PMID:
25896145.
Article
33. Oh HK, Kang SB, Lee SM, Lee SY, Ihn MH, Kim DW, et al. 2014; Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol. 21:2280–2287. DOI:
10.1245/s10434-014-3559-z. PMID:
24604580.
Article
34. Malakorn S, Yang Y, Bednarski BK, Kaur H, You YN, Holliday EB, et al. 2019; Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation? Dis Colon Rectum. 62:1158–1166. DOI:
10.1097/DCR.0000000000001465. PMID:
31490825.
Article
36. Georgiou PA, Mohammed Ali S, Brown G, Rasheed S, Tekkis PP. 2017; Extended lymphadenectomy for locally advanced and recurrent rectal cancer. Int J Colorectal Dis. 32:333–340. DOI:
10.1007/s00384-016-2711-6. PMID:
28130592. PMCID:
PMC5316388.
Article
37. Matsuda T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, et al. 2018; Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis. 33:367–374. DOI:
10.1007/s00384-018-2974-1. PMID:
29442155.
Article
38. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, et al. 2006; Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 49:1663–1672. DOI:
10.1007/s10350-006-0714-z. PMID:
17041749.
Article
39. Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K, et al. 2012; Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg. 255:1129–1134. DOI:
10.1097/SLA.0b013e3182565d9d. PMID:
22549752.
Article
40. Schaap DP, Boogerd LS, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, et al. 2021; Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg. 108:205–213. DOI:
10.1093/bjs/znaa009. PMID:
33711144.
Article
41. Son KM, Ahn H, Lee IY, Ha GW. 2021; Multifunctional indocyanine green applications for fluorescence-guided laparoscopic colorectal surgery. Ann Coloproctol. 37:133–140. DOI:
10.3393/ac.2021.05.07. PMID:
34102813. PMCID:
PMC8273708.
Article
42. Kawada K, Yoshitomi M, Inamoto S, Sakai Y. 2019; Indocyanine green fluorescence-guided laparoscopic lateral lymph node dissection for rectal cancer. Dis Colon Rectum. 62:1401. DOI:
10.1097/DCR.0000000000001475. PMID:
31596765.
Article
43. Yamaguchi T, Konishi T, Kinugasa Y, Yamamoto S, Akiyoshi T, Okamura R, et al. 2017; Laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer: a subgroup analysis of a large multicenter cohort study in Japan. Dis Colon Rectum. 60:954–964. DOI:
10.1097/DCR.0000000000000843. PMID:
28796734.
Article
44. Ogura A, Akiyoshi T, Nagasaki T, Konishi T, Fujimoto Y, Nagayama S, et al. 2017; Feasibility of laparoscopic total mesorectal excision with extended lateral pelvic lymph node dissection for advanced lower rectal cancer after preoperative chemoradiotherapy. World J Surg. 41:868–875. DOI:
10.1007/s00268-016-3762-0. PMID:
27730352.
Article
46. Peacock O, Limvorapitak T, Bednarski BK, Kaur H, Taggart MW, Dasari A, et al. 2020; Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective. Colorectal Dis. 22:2049–2056. DOI:
10.1111/codi.15350. PMID:
32892473.
Article
47. Bae SU, Saklani AP, Hur H, Min BS, Baik SH, Lee KY, et al. 2014; Robotic and laparoscopic pelvic lymph node dissection for rectal cancer: short-term outcomes of 21 consecutive series. Ann Surg Treat Res. 86:76–82. DOI:
10.4174/astr.2014.86.2.76. PMID:
24761412. PMCID:
PMC3994600.
Article
48. Kim HJ, Choi GS, Park JS, Park SY, Lee HJ, Woo IT, et al. 2018; Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach. Surg Endosc. 32:2466–2473. DOI:
10.1007/s00464-017-5948-4. PMID:
29124406.
Article
49. Kim CW, Jeong WK, Son GM, Kim IY, Park JW, Jeong SY, et al. 2020; Validation of Korean Version of Low Anterior Resection Syndrome Score Questionnaire. Ann Coloproctol. 36:83–87. DOI:
10.3393/ac.2019.08.01. PMID:
32054239. PMCID:
PMC7299562.
Article
50. Piozzi GN, Kim SH. 2021; Robotic intersphincteric resection for low rectal cancer: technical controversies and a systematic review on the perioperative, oncological, and functional outcomes. Ann Coloproctol. 37:351–367. DOI:
10.3393/ac.2021.00836.0119. PMID:
34784706. PMCID:
PMC8717069.
Article